Reuters
20 Aug 2026, 11:02 UTC · 1h ago
Congo set to receive 70,000 Ervebo vaccines to contain Ebola outbreak, WHO says
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
Reuters
20 Aug 2026, 11:02 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
1 claim · each scored for market impact
The Democratic Republic of Congo has been allocated 70,000 doses of Merck's Ervebo vaccine to combat its largest Ebola outbreak. — While positive for Merck's product utility, the quantity is relatively small in the context of global pharmaceutical revenue.
+0.10Which stocks this story touches
The company is providing 70,000 doses of its Ervebo vaccine to help contain an Ebola outbreak.
Continue reading
6 related stories
Top 1 mover · tap to explore
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Invezz
16h ago
